The purview of basic cancer research is to address the fundamental mechanisms of biological processes that underlie the initiation and the progression of cancer. Over the past 2 decades, studies of cancer biology have led to the establishment of a general framework for tumor development. In this framework, a series of 8 biological events required for the formation of cancer have been identified: (a) increased cell proliferation, (b) decreased cell death, (c) defects in terminal differentiation, (d) escape from life-span restriction, (e) genome instability, (f) immune evasion, (g) angiogenesis, and (h) invasion and metastasis. Members of the Cancer Biology and Signaling (CBS) Program conduct basic research on the biological processes that underlie the initiation and progression of cancer. The scientific goals of the CBS Program are to fill some of those gaps in knowledge, focusing on fundamental mechanisms in 2 general areas of biology: signal transduction and cell growth. The CBS program has 34 members from 8 academic departments with $14.3 Million of peer-reviewed research grant funding (annual direct costs), including $3.4 Million from NCI. Members of the CBS Program published 751 programmatically aligned articles (2007-2012);10% were the result of intra-programmatic collaborations, 15% were inter-programmatic. Members participate in a monthly luncheon seminar series to exchange research results. The Cancer Center adds value to the research projects in CBS by providing shared facilities, consultation on state of the art technologies, human tissue samples, seed grants for translational research, and recruitment of outstanding investigators to Cancer Center Programs.
The mission of the Moores Cancer Center is to translate research discoveries into meaningful advances to prevent, ameliorate and eliminate the burden of cancer. Members of the Cancer Biology and Signaling Program conduct basic research on the biological processes that underlie the initiation and progression of Cancer.
|Sen, Supriya; Langiewicz, Magda; Jumaa, Hassan et al. (2015) Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice. Hepatology 61:171-83|
|Hoffmann, Hanne M; Tamrazian, Anika; Xie, Huimin et al. (2014) Heterozygous deletion of ventral anterior homeobox (vax1) causes subfertility in mice. Endocrinology 155:4043-53|
|Hartman, Lisa L R; Crawford, John R; Makale, Milan T et al. (2014) Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors. J Pediatr Hematol Oncol 36:451-7|
|Williams, Richard T; Barnhill, Lisa M; Kuo, Huan-Hsien et al. (2014) Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth. PLoS One 9:e88219|
|Huang, Carlos P; Fofana, Mariama; Chan, Jefferson et al. (2014) Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin. Metallomics 6:654-61|
|Paolini, Paul; Pick, Daniel; Lapira, Jennifer et al. (2014) Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes. Pharmacogenomics 15:759-74|
|Goellner, Eva M; Smith, Catherine E; Campbell, Christopher S et al. (2014) PCNA and Msh2-Msh6 activate an Mlh1-Pms1 endonuclease pathway required for Exo1-independent mismatch repair. Mol Cell 55:291-304|
|Glidewell-Kenney, Christine A; Trang, Crystal; Shao, Paul P et al. (2014) Neurokinin B induces c-fos transcription via protein kinase C and activation of serum response factor and Elk-1 in immortalized GnRH neurons. Endocrinology 155:3909-19|
|Jiang, P; Mukthavaram, R; Chao, Y et al. (2014) In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. Br J Cancer 111:1562-71|
|Jacques, Bonnie E; Montgomery 4th, William H; Uribe, Phillip M et al. (2014) The role of Wnt/*-catenin signaling in proliferation and regeneration of the developing basilar papilla and lateral line. Dev Neurobiol 74:438-56|
Showing the most recent 10 out of 359 publications